False Claims-Qui Tam

In Fiscal Year 2020, the U.S. Department of Justice announced that out of $2.2 billion recovered from False Claims Act (FCA) settlements and judgements, $1.6 billion came from qui tam cases. In anticipation of the report for Fiscal Year 2021,...

Michigan-based pharmacist Riad “Ray” Zahr and two specialty pharmacies that he “formerly owned and operated” will pay the U.S. $1 million “to resolve allegations that they submitted false claims for the drug Evzio,” according to a December 8 U.S. Department...

On December 2, the U.S. Department of Justice announced that Flower Mound Hospital Partners LLC will pay $18.2 million to resolve allegations that it violated the False Claims Act. The whistleblower responsible for bringing the qui tam case against Flower...

On November 23, the U.S. Department of Justice (DOJ) announced that a hospice care provider will pay $5.5 million “to resolve allegations that they violated the False Claims Act by submitting claims to Medicare for non-covered hospice services.” Carrefour Associates...

The U.S. Department of Justice (DOJ) announced that on November 8, the U.S. District Court for the District of North Carolina “entered a $9 million civil consent judgment for the United States” against chiropractor Daniel McCollum. The judgement was entered...

The qui tam provisions of the False Claims Act (FCA) allow private citizens to file lawsuits on behalf of the U.S. government if an individual or a company is defrauding the government. If the government is able to make recoveries...

At 9:00am Eastern Time on October 28, the Senate Judiciary Committee voted to advance a bipartisan False Claims Act amendments bill onto the floor of the U.S. Senate. The bill passed with 15 yes votes and 7 votes of no....

Senator Chuck Grassley (R-IA) is taking another swing at passing crucial amendments to the False Claims Act that would solve various issues with the landmark anti-corruption and whistleblowing law, mostly created by recent judicial interpretations of the Act. Advocacy group...

Two home-based healthcare service providers, U.S. Medical Management, LLC (USMM) and VPA, P.C. (VPA) settled whistleblower claims that they submitted unnecessary testing bills to the Medicare program, resulting in the allegedly wrongful payment of millions of dollars over a five-year...

Generic pharmaceutical manufacturers, Taro Pharmaceuticals USA, Inc., Sandoz Inc. and Apotex Corporation, will pay $447.2 million to settle allegations that they conspired to artificially inflate the price of multiple generic drugs. According to a U.S. Department of Justice (DOJ) press...